Orbit CEO, Neil Butt will be attending the 2024 European Association for Nuclear Medicine Congress in Hamburg, Germany from October 19th to 23rd. Come learn more about how Orbit is helping leading radiopharmaceutical companies discover novel peptide conjugates for radionuclide delivery.